Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
US Army

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,677,331

« Back to Dashboard

Summary for Patent: 5,677,331

Title: Antimalarial compositions
Abstract:The invention relates to a synergistic antimalarial composition which comprises the antimalarial agent benflumetol and also an antimalarial agent from the artemisinine group such as artemether. The composition can be formulated into solid dosage forms such as tablets and is useful for the treatment of drug resistant malaria.
Inventor(s): Zhou; Yiqing (Beijing, CN), Ning; Dianxi (Beijing, CN), Wang; Shufen (Beijing, CN), Ding; Deben (Beijing, CN), Li; Guofu (Beijing, CN), Shan; Chengqi (Beijing, CN), Liu; Guangyu (Beijing, CN)
Assignee: Ciba-Geigy AG (Basel, CH) Institute of Microbiology and Epidemiology, Academy of Military Medical (Beijing, CN)
Application Number:08/216,440
Patent Claim Types:
see list of patent claims
Composition; Compound; Delivery; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,677,331

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
China90106722.9Aug 08, 1990
China91102575.8Apr 24, 1991

International Patent Family for Patent: 5,677,331

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Greece3019313► Subscribe
China1058717► Subscribe
China1085527► Subscribe
Germany10199038► Subscribe
Germany69117922► Subscribe
Denmark0500823► Subscribe
Egypt19905► Subscribe
European Patent Office0500823► SubscribeSPC/GB00/013United Kingdom► Subscribe
European Patent Office0500823► SubscribeC300048Netherlands► Subscribe
European Patent Office0500823► Subscribe2001C/043Belgium► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus